Patients with Polycystic Ovary Syndrome Have Successful Embryo Arrest

Overview

Journal Int J Clin Exp Med

Specialty General Medicine

Date 2015 Jul 2

PMID 26131233

Citations 5

Authors

Baoli Yin

Haoying Hao

Duo Wei

Xiaobing Song

Juanke Xie

Cuilian Zhang

Affiliations

Soon will be listed here.

Abstract

In this retrospective study, we investigate the relationship between embryo arrest and polycystic ovary syndrome (PCOS) during in vitro fertilization-embryo transfer (IVF-ET). In this study, 667 subjects were enrolled, including 330 patients with PCOS and 337 subjects without PCOS. The subjects underwent in vitro fertilization/intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET) cycles at the Reproductive Medical Centre of Henan Provincial Hospital from January 2009 to December 2012. Four protocols were used to stimulate the ovaries, including long protocol, super-long down-regulation protocol, short protocol and antagonist protocol. Oocytes were retrieved using transvaginal ultrasound guidance. Pronuclei were checked on the next morning after IVF/ICSI. Cleavage stage embryo was assessed after 62-66 hours. Women with PCOS had significantly elevated body mass index, basal luteinizing hormone, estradiol and testosterone compared with normal women. Basal Follicle stimulating hormone level in PCOS patients was lower compared with that in control group. After IVF-ET, PCOS patients had more available oocytes than subjects in control group. PCOS patients had slightly lower fertilization rate than the controls in IVF cycles, but in ICSI cycles, fertilization rate in PCOS patients was significantly higher than that in controls. For either IVF or ICSI, the embryo arrest rate was not changed by PCOS. Moreover, there was no significant difference in embryo arrest rate between both groups adopting different stimulation protocols. Interestingly, embryo arrest rate was not correlated with testosterone for patients in PCOS group. The data indicated that patients with PCOS had successful early embryo arrest during IVF-ET.

Citing Articles

Molecular characterization of extracellular vesicles derived from follicular fluid of women with and without PCOS: integrating analysis of differential miRNAs and proteins reveals vital molecules involving in PCOS.

Yang Y, Lang P, Zhang X, Wu X, Cao S, Zhao C J Assist Reprod Genet. 2023; 40(3):537-552.

PMID: 36695944 PMC: 10033803. DOI: 10.1007/s10815-023-02724-z.

The effect of curcumin on embryonic in vitro development in experimental polycystic ovary syndrome: An experimental study.

Nasiri Bari Y, Babapour V, Ahmadi A, Zendehdel Kheybari M, Akbari G Int J Reprod Biomed. 2022; 19(11):997-1004.

PMID: 34977457 PMC: 8717079. DOI: 10.18502/ijrm.v19i11.9915.

Competence of embryos showing transient developmental arrest during in vitro culture.

Montjean D, Geoffroy-Siraudin C, Gervoise-Boyer M, Boyer P J Assist Reprod Genet. 2021; 38(4):857-863.

PMID: 33532884 PMC: 8079528. DOI: 10.1007/s10815-021-02090-8.

Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review.

Reyes-Munoz E, Sathyapalan T, Rossetti P, Shah M, Long M, Buscema M Adv Ther. 2018; 35(11):1805-1815.

PMID: 30311070 PMC: 6224003. DOI: 10.1007/s12325-018-0810-1.

Effects of Negative Emotions and Life Events on Women's Missed Miscarriage.

Xing H, Luo Y, Wang S Iran J Public Health. 2018; 47(2):219-224.

PMID: 29445631 PMC: 5810384.

References

Agarwal A, Saleh R, Bedaiwy M . Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003; 79(4):829-43. DOI: 10.1016/s0015-0282(02)04948-8. View

Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T . High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod. 1995; 10(8):1962-7. DOI: 10.1093/oxfordjournals.humrep.a136217. View

Betts D, King W . Genetic regulation of embryo death and senescence. Theriogenology. 2001; 55(1):171-91. DOI: 10.1016/s0093-691x(00)00453-2. View

MacDougall M, Tan S, Balen A, Jacobs H . A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod. 1993; 8(2):233-7. DOI: 10.1093/oxfordjournals.humrep.a138029. View

Stadtmauer L, Toma S, Riehl R, TALBERT L . Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril. 2001; 75(3):505-9. DOI: 10.1016/s0015-0282(00)01766-0. View

Qiao J, Feng H . Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2010; 17(1):17-33. PMC: 3001338. DOI: 10.1093/humupd/dmq032. View

Sengoku K, Tamate K, Takuma N, Yoshida T, Goishi K, Ishikawa M . The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome. Hum Reprod. 1997; 12(3):474-7. DOI: 10.1093/humrep/12.3.474. View

Byrne A, Southgate J, Brison D, Leese H . Analysis of apoptosis in the preimplantation bovine embryo using TUNEL. J Reprod Fertil. 2000; 117(1):97-105. DOI: 10.1530/jrf.0.1170097. View

Marci R, Senn A, Dessole S, Chanson A, Loumaye E, De Grandi P . A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins. Fertil Steril. 2001; 75(6):1131-5. DOI: 10.1016/s0015-0282(01)01788-5. View

10.

Matwee C, Betts D, King W . Apoptosis in the early bovine embryo. Zygote. 2000; 8(1):57-68. DOI: 10.1017/s0967199400000836. View

11.

Tarlatzis B, Grimbizis G . The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization. J Assist Reprod Genet. 1997; 14(1):1-4. PMC: 3454715. DOI: 10.1007/BF02765740. View

12.

Dor J, Shulman A, Levran D, Ben-Rafael Z, Rudak E, Mashiach S . The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. Hum Reprod. 1990; 5(7):816-8. DOI: 10.1093/oxfordjournals.humrep.a137189. View

13.

Homburg R, Berkowitz D, Levy T, Feldberg D, Ashkenazi J, Ben-Rafael Z . In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril. 1993; 60(5):858-63. DOI: 10.1016/s0015-0282(16)56287-6. View

14.

Hardy K, Spanos S, Becker D, Iannelli P, Winston R, Stark J . From cell death to embryo arrest: mathematical models of human preimplantation embryo development. Proc Natl Acad Sci U S A. 2001; 98(4):1655-60. PMC: 29312. DOI: 10.1073/pnas.98.4.1655. View

15.

Zhong Y, Li J, Ying Y, Wu H, Zhou C, Xu Y . The efficacy of conversion from IUI to IVF-ET in infertility patients with hyper-response to ovulation induction: a retrospective study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012; 156(2):159-63. DOI: 10.5507/bp.2012.044. View

16.

Feenan K, Herbert M . Can 'abnormally' fertilized zygotes give rise to viable embryos?. Hum Fertil (Camb). 2006; 9(3):157-69. DOI: 10.1080/14647270600636269. View

17.

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1):19-25. DOI: 10.1016/j.fertnstert.2003.10.004. View

18.

Doldi N, Marsiglio E, Destefani A, Gessi A, Merati G, Ferrari A . Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod. 1999; 14(3):601-5. DOI: 10.1093/humrep/14.3.601. View

19.

Salvetti N, Ortega H, Veiga-Lopez A, Padmanabhan V . Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep. Biol Reprod. 2012; 87(1):22, 1-10. PMC: 3406557. DOI: 10.1095/biolreprod.112.100024. View

20.

Ludwig M, Finas D, Al-Hasani S, Diedrich K, Ortmann O . Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod. 1999; 14(2):354-8. DOI: 10.1093/humrep/14.2.354. View